| Code | 02760 | ||||||||||
| MA number | 56/0933/10-S | ||||||||||
| Product Form: | plu igf 1x22,5 mg+1x2 ml disp.prostr.(liek.inj.skl.+amp.skl.+blis.1 str.inj.+2 ihly) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Mutual recognition procedure | ||||||||||
| MAH, country: | Ipsen Pharma, France | ||||||||||
| Therapeutic Class: | 56 - HORMONA (LIEČIVA S HORMONÁLNOU AKTIVITOU) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 48 | ||||||||||
| Container: | glass vial | ||||||||||
| Route of admin.: | Intramuscular use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 8(3) application - known active substance |
| MA issued: | 16.12.2010 |
| SPC: |
SPC_Diphereline S.R. 22,5 mg_10_2023.pdf
|
| PIL: |
PIL_Diphereline 22.5mg_10_2023.pdf
|
| Safety feature | Yes |
| Data update: | 03.10.2023 |
